China
People familiar with the matter said that relevant consultations are still in progress, and details such as the scale and timing of fundraising may be adjusted. A spokesperson for the SoftBank Vision Fund declined to comment, and representatives of Abogen and Mirae Asset did not immediately respond to requests for comment or were unable to …
Dec 23, 2021，CanSino Biologics Inc. announced that The Lancet published its Phase III clinical trial results on the safety and efficacy of its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (“Ad5-nCoV”, trade name: Convidecia™). The publication of the analysis showed that a single dose of Convidecia™ is efficacious and safe with an efficacy of 96.0% in preventing …
Nugene Biopharm Science (Hangzhou) Co., Ltd. is investing 200 million yuan to build a commercial production base and a research and development center, that can meet the urgently needed supply of key raw materials in the mRNA industry chain. The 6000 square meter research and development center has been completed, providing global mRNA customers with …
GMP site for the urgently needed supply of key raw materials in the mRNA industry chain Read More »
“I think the research and development of innovative new drugs requires a long-term process. You can stand on the shoulders of giants to gain certain advantages, but it is impossible overnight. Investors choose Jiachen Xihai to value our stable construction and vision.” In early 2021, Jiachen Xihai announced the completion of a series A financing …
Immorna announced the completion of a round A financing of more than RMB 100 million Read More »
